Frank X. Leonard, Chief Development Officer at NovoCure Ltd (NVCR), sold 414 shares at $69.66 ($29K) on 2022-08-02, disclosed to the SEC on 2022-08-03.
Open-market sale of $29k NVCR by Chief Development Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| NVCR | SELL | 2026-03-03 | $231K | — | Filing → |
| NVCR | SELL | 2025-06-04 | $1.0M | — | Filing → |
| NVCR | SELL | 2025-03-04 | $47K | — | Filing → |